SummitTX Capital, L.P.

Position in ADPT — Adaptive Biotechnologies Corp

CIK 2052310 FORT WORTH, TX

Position in ADPT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,408,621

New position

Shares Held

317,624

first reported quarter

Ownership

0.198%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SummitTX Capital, L.P. holds $8,516,531 across 5 Diagnostics & Research names. ADPT ranks #1 (51.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ADPT	Adaptive Biotechnologies Corp This page	317,624	$4,408,621
2	CSTL	Castle Biosciences Inc	67,033	$1,645,660
3	A	Agilent Technologies, Inc.	9,525	$1,085,659
4	RVTY	Revvity, Inc.	11,512	$1,008,566
5	IQV	Iqvia Holdings Inc.	2,158	$368,025

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,408,621	317,624	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.